RT-QuIC assays of alpha-synuclein aggregation are abnormal in PD and DLB patients, and people with mutations or triplications in alpha-synuclein are at increased risk for developing PD or DLB (Singleton et al., 2003). Here, SNCA is linked to Parkinson disease.